Skip to the content
  • HOME
  • ABOUT
  • ACTHIV INSTITUTE
  • SERVICES
  • CE ACTIVITIES
    • Cardiology
    • Hematology
    • HIV Medicine
    • Infectious Disease
    • Nephrology
    • Oncology
    • Rare Diseases
  • RESOURCES
  • CONTACT

AACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes

  • Post author By salmocc
  • Post date July 21, 2026

AACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes

 Cardiology

Physicians

American Academy of CME, Inc., designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses

American Academy of CME, Inc., designates this educational activity for 0.25 ANCC contact hours (0.1 pharmacotherapeutic contact hours).

Physician Assistants

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 6/16/2027. PAs should only claim credit commensurate with the extent of their participation.

Other HCPs:

Other members of the care team will receive a certificate of participation.

  • Listing ID: 3451

← The Cortisol Clue: Diagnosing Hypercortisolism in People with Difficult-to-Control Cardiometabolic Conditions → AACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes